NeuroSense Therapeutics Ltd

NASDAQ:NRSN   3:59:54 PM EDT
1.90
+0.03 (+1.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

NeuroSense Therapeutics Ltd Stock, NASDAQ:NRSN

11 HaMenofim Street, Building B, Herzliya, Tel Aviv 46725
Israel
Phone: +972.9.799.6183
Number of Employees:

Description

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimerâ??s and Parkinsonâ??s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.